Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ?20%

dc.authoridTanriverdi, Ozgur/0000-0002-0598-7284
dc.authoridHacioglu, Bekir/0000-0001-8490-3239
dc.authoridUysal, Mukremin/0000-0002-8524-0665
dc.authoridduran, Ayse Ocak/0000-0002-1703-726X;
dc.authorwosidTanriverdi, Ozgur/M-2172-2015
dc.authorwosidozcelik, melike/AAS-7557-2020
dc.authorwosidÖZASLAN, ERSİN/V-3556-2017
dc.authorwosidHacioglu, Bekir/GZH-1824-2022
dc.authorwosidSevinc, Alper/KFQ-6440-2024
dc.authorwosidUysal, Mukremin/B-8956-2014
dc.authorwosidduran, Ayse Ocak/ABA-7090-2021
dc.contributor.authorOzaslan, E.
dc.contributor.authorKoca, S.
dc.contributor.authorSevinc, A.
dc.contributor.authorHacioglu, B.
dc.contributor.authorOzcelik, M.
dc.contributor.authorDuran, A. O.
dc.contributor.authorYildiz, Y.
dc.date.accessioned2024-06-12T11:15:25Z
dc.date.available2024-06-12T11:15:25Z
dc.date.issued2016
dc.departmentTrakya Üniversitesien_US
dc.description13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease -- MAR 09-11, 2016 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipENETSen_US
dc.identifier.endpage74en_US
dc.identifier.issn0028-3835
dc.identifier.issn1423-0194
dc.identifier.startpage74en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23925
dc.identifier.volume103en_US
dc.identifier.wosWOS:000386481600195en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofNeuroendocrinologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSomatostatin Analogueen_US
dc.subjectNETen_US
dc.subjectKi-67en_US
dc.titleComparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ?20%en_US
dc.typeConference Objecten_US

Dosyalar